What We Do

Our leadership in essential plasma-derived medicines enable patients with rare and chronic diseases – sometimes life-threatening – to lead healthier lives. They often have no alternative treatments. We produce our lifesaving medicines, made from plasma proteins, thanks to the generosity of donors who entrust their donations to our growing global network of donor centers, the world’s largest.

Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently deliver medical care.

As Grifols grew into a global plasma leader over the last 50 years, the company became increasingly known for its industrial excellence, with advanced machinery, robotics and equipment for highly sophisticated and efficient manufacturing operations.

Grifols Engineering designs and builds the company’s global production facilities, continuously setting industry standards for precision performance, sustainability and outstanding quality. Its singular excellence draws on Grifols’ commitment to continuous innovation.

Such is its reputation that Grifols Engineering provides its services to the wider biopharmaceutical and biotechnology sectors.